Logo image of ID

PARTS ID INC (ID) Stock Fundamental Analysis

NYSEARCA:ID - NYSE Arca - US7021411027 - Common Stock - Currency: USD

0.0489  -0.04 (-43.34%)

Fundamental Rating

1

ID gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. ID may be in some trouble as it scores bad on both profitability and health. ID is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ID has reported negative net income.
ID had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ID reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ID reported negative operating cash flow in multiple years.
ID Yearly Net Income VS EBIT VS OCF VS FCFID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

1.2 Ratios

With a Return On Assets value of -125.53%, ID is not doing good in the industry: 96.90% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -125.53%
ROE N/A
ROIC N/A
ROA(3y)-37.31%
ROA(5y)-22.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ID Yearly ROA, ROE, ROICID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 50 -50 100 150

1.3 Margins

ID has a Gross Margin of 18.47%. This is amonst the worse of the industry: ID underperforms 82.17% of its industry peers.
The Profit Margin and Operating Margin are not available for ID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ID Yearly Profit, Operating, Gross MarginsID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 5 -5 10 15 20

0

2. Health

2.1 Basic Checks

ID does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ID has more shares outstanding
ID has a worse debt/assets ratio than last year.
ID Yearly Shares OutstandingID Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
ID Yearly Total Debt VS Total AssetsID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

ID has an Altman-Z score of -0.77. This is a bad value and indicates that ID is not financially healthy and even has some risk of bankruptcy.
ID's Altman-Z score of -0.77 is on the low side compared to the rest of the industry. ID is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACC8.54%
ID Yearly LT Debt VS Equity VS FCFID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M

2.3 Liquidity

A Current Ratio of 0.12 indicates that ID may have some problems paying its short term obligations.
ID's Current ratio of 0.12 is on the low side compared to the rest of the industry. ID is outperformed by 99.22% of its industry peers.
A Quick Ratio of 0.10 indicates that ID may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.10, ID is doing worse than 95.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.1
ID Yearly Current Assets VS Current LiabilitesID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2

3. Growth

3.1 Past

ID shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -120.83%.
Looking at the last year, ID shows a very negative growth in Revenue. The Revenue has decreased by -57.44% in the last year.
EPS 1Y (TTM)-120.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)-57.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.56%

3.2 Future

ID is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.87% yearly.
The Revenue is expected to grow by 6.05% on average over the next years.
EPS Next Y74.74%
EPS Next 2Y46.15%
EPS Next 3Y34.04%
EPS Next 5Y28.87%
Revenue Next Year3.26%
Revenue Next 2Y4.62%
Revenue Next 3Y5.41%
Revenue Next 5Y6.05%

3.3 Evolution

ID Yearly Revenue VS EstimatesID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ID Yearly EPS VS EstimatesID Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

4

4. Valuation

4.1 Price/Earnings Ratio

ID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 0.68, the valuation of ID can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ID indicates a rather cheap valuation: ID is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. ID is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.68
ID Price Earnings VS Forward Price EarningsID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ID Per share dataID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ID's earnings are expected to grow with 34.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.15%
EPS Next 3Y34.04%

0

5. Dividend

5.1 Amount

ID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PARTS ID INC

NYSEARCA:ID (12/26/2023, 8:04:00 PM)

0.0489

-0.04 (-43.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-14 2023-11-14
Earnings (Next)04-15 2024-04-15/amc
Inst Owners0.04%
Inst Owner Change0%
Ins Owners10.63%
Ins Owner Change0%
Market Cap1.70M
Analysts40
Price Target1.02 (1985.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-83.65%
Min Revenue beat(2)-85.72%
Max Revenue beat(2)-81.58%
Revenue beat(4)0
Avg Revenue beat(4)-50.48%
Min Revenue beat(4)-85.72%
Max Revenue beat(4)-9.42%
Revenue beat(8)1
Avg Revenue beat(8)-29.43%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.68
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)0.07
Fwd EY147.44%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS4.99
BVpS-1.02
TBVpS-1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -125.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.47%
FCFM N/A
ROA(3y)-37.31%
ROA(5y)-22.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover9.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.85%
Cap/Sales 2.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.1
Altman-Z -0.77
F-Score2
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)93.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-120.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y74.74%
EPS Next 2Y46.15%
EPS Next 3Y34.04%
EPS Next 5Y28.87%
Revenue 1Y (TTM)-57.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.56%
Revenue Next Year3.26%
Revenue Next 2Y4.62%
Revenue Next 3Y5.41%
Revenue Next 5Y6.05%
EBIT growth 1Y-29.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.34%
EBIT Next 3Y52.05%
EBIT Next 5Y44.28%
FCF growth 1Y-172.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-135.44%
OCF growth 3YN/A
OCF growth 5YN/A